Nobalanda B. Mokoena

100 Old Soutpan Road
Onderstepoort, GT 0110, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Plasmid DNA-based reverse genetics as a platform for manufacturing of bluetongue vaccine.

Plasmid DNA-based reverse genetics as a platform for manufacturing of bluetongue vaccine.

Journal: Journal of virology

Published: March 25, 2025

Genome sequences of the 15 bluetongue virus vaccine strains incorporated in the South African live-attenuated vaccine.

Genome sequences of the 15 bluetongue virus vaccine strains incorporated in the South African live-attenuated vaccine.

Journal: Microbiology resource announcements

Published: May 21, 2024

Safety and Efficacy of Plant-Produced Trivalent Virus-Like Particle Vaccine Candidate Against Bluetongue Disease.

Safety and Efficacy of Plant-Produced Trivalent Virus-Like Particle Vaccine Candidate Against Bluetongue Disease.

Journal: Plant biotechnology journal

Published: January 22, 2024

Production of recombinant lumpy skin disease virus A27L and L1R proteins for application in diagnostics and vaccine development.

Production of recombinant lumpy skin disease virus A27L and L1R proteins for application in diagnostics and vaccine development.

Journal: Vaccine: X

Published: June 24, 2023

Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep.

Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep.

Journal: Virology journal

Published: June 15, 2023

Rift Valley Fever vaccine strategies: Enhanced stability of RVF Clone 13.

Rift Valley Fever vaccine strategies: Enhanced stability of RVF Clone 13.

Journal: Vaccine

Published: September 19, 2022

Improved safety profile of inactivated Neethling strain of the Lumpy Skin Disease Vaccine.

Improved safety profile of inactivated Neethling strain of the Lumpy Skin Disease Vaccine.

Journal: Vaccine: X

Published: June 07, 2022

Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR-/- mice.

Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR-/- mice.

Journal: Vaccine

Published: March 25, 2022

Genome sequence of Bovine Ephemeral fever virus vaccine strain of South African origin.

Genome sequence of Bovine Ephemeral fever virus vaccine strain of South African origin.

Journal: Veterinary medicine and science

Published: August 31, 2020

Application of a real-time cell analysis system in the process development and quantification of Rift Valley fever virus clone 13.

Application of a real-time cell analysis system in the process development and quantification of Rift Valley fever virus clone 13.

Journal: Access microbiology

Published: August 15, 2020

Protection of Cattle Elicited Using a Bivalent Lumpy Skin Disease Virus-Vectored Recombinant Rift Valley Fever Vaccine.

Protection of Cattle Elicited Using a Bivalent Lumpy Skin Disease Virus-Vectored Recombinant Rift Valley Fever Vaccine.

Journal: Frontiers in veterinary science

Published: January 08, 2020

Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.

Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.

Journal: BMC veterinary research

Published: June 06, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026